AllaChem Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

AllaChem General Information

Description

Developer of drugs intended to emphasize a rational approach that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies. The company's drugs are offered with improved pharmacokinetics, efficacy, and safety properties which are used in the treatment of infectious diseases, cancer, and central nervous system disorders, enabling physicians to deliver improved treatment to their patients thereby improving the outcome.

Contact Information

Website
www.allachem.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1835 East Hallandale Beach Boulevard
  • Suite 442
  • Hallandale Beach, FL 33009
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • 1835 East Hallandale Beach Boulevard
  • Suite 442
  • Hallandale Beach, FL 33009
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AllaChem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Apr-2022 Completed Out of Business
1. Later Stage VC Completed Generating Revenue
To view AllaChem’s complete valuation and funding history, request access »

AllaChem Patents

  • 129

    Total Documents Applications and Grants

  • Total Patents Families

  • 47

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

AllaChem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240415944-A1 Aqueous aprotinin-containing antiviral pharmaceutical composition Pending 06-Apr-2021
EP-4137208-A1 Noradrenergic and specific serotonergic anxiolytic and antidepressant, and method for producing same and using same Pending 19-Mar-2020
EP-4137208-A4 Noradrenergic and specific serotonergic anxiolytic and antidepressant, and method for producing same and using same Pending 19-Mar-2020
US-20240238260-A1 Noradrenergic and specific serotonergic anxiolytic and antidepressant, method for the production and use thereof Pending 19-Mar-2020
EP-3978503-A4 Annelated 9-hydroxy-1,8-dioxo-1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine-7-carboxamides as hiv integrase inhibitors Inactive 03-Jun-2019 A61K9/08
To view AllaChem’s complete patent history, request access »

Ready to get started?

Request a free trial

AllaChem FAQs

  • When was AllaChem founded?

    AllaChem was founded in 2004.

  • Where is AllaChem headquartered?

    AllaChem is headquartered in Hallandale Beach, FL.

  • What industry is AllaChem in?

    AllaChem’s primary industry is Drug Discovery.

  • Is AllaChem a private or public company?

    AllaChem is a Private company.

  • What is AllaChem’s current revenue?

    The current revenue for AllaChem is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »